Inspection Record

Strive Pharmacy Texas LLC — FDA 483 Findings

US FDAInspected 2023-09-08Published 2023-10-12 4 findingsEquipment and facilityAseptic processing and sterility assurance

Inspectors Camerson E MooreThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

The facility design was observed to allow the influx of lesser quality air into a classified area containing higher quality air.

2Equipment and facility

Cleaning of equipment and glassware is inadequate.

3Equipment and facility

Failure to appropriately and regularly clean and disinfect or sterilize equipment located in the ISO 5 area.

4Aseptic processing and sterility assurance

Personnel performed aseptic manipulations with exposed hair or skin.

About this record

Extracted automatically from the document US FDA published on 2023-10-12. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Strive Pharmacy Texas LLC company profile — full history US FDA documents, 2023 Go to Findings search